BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15925706)

  • 1. How individual sensitivity to opiates can be predicted by gene analyses.
    Ikeda K; Ide S; Han W; Hayashida M; Uhl GR; Sora I
    Trends Pharmacol Sci; 2005 Jun; 26(6):311-7. PubMed ID: 15925706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there genetic polymorphism evidence for individual human sensitivity to opiates?
    Nagashima M; Katoh R; Sato Y; Tagami M; Kasai S; Ikeda K
    Curr Pain Headache Rep; 2007 Apr; 11(2):115-23. PubMed ID: 17367590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
    Lötsch J; Geisslinger G
    Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of opioid and gene variants].
    Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
    Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
    Fukuda K; Hayashida M; Ide S; Saita N; Kokita Y; Kasai S; Nishizawa D; Ogai Y; Hasegawa J; Nagashima M; Tagami M; Komatsu H; Sora I; Koga H; Kaneko Y; Ikeda K
    Pain; 2009 Dec; 147(1-3):194-201. PubMed ID: 19783098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible genetic mechanism underlying individual and interstrain differences in opioid actions: focus on the mu opioid receptor gene.
    Han W; Ide S; Sora I; Yamamoto H; Ikeda K
    Ann N Y Acad Sci; 2004 Oct; 1025():370-5. PubMed ID: 15542738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
    Hayashida M; Maruyama K
    Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?].
    Fukuda K; Hayashida M; Ikeda K
    Masui; 2009 Sep; 58(9):1102-8. PubMed ID: 19764432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.
    Ide S; Kobayashi H; Ujike H; Ozaki N; Sekine Y; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Iwata N; Tanaka K; Shen H; Iwahashi K; Itokawa M; Minami M; Satoh M; Ikeda K; Sora I
    Pharmacogenomics J; 2006; 6(3):179-88. PubMed ID: 16402083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genetic factors on opioid action.
    Kosarac B; Fox AA; Collard CD
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA.
    Ide S; Han W; Kasai S; Hata H; Sora I; Ikeda K
    Gene; 2005 Dec; 364():139-45. PubMed ID: 16122888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of the human µ-opioid receptor.
    Kasai S; Ikeda K
    Pharmacogenomics; 2011 Sep; 12(9):1305-20. PubMed ID: 21919606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains.
    Shigeta Y; Kasai S; Han W; Hata H; Nishi A; Takamatsu Y; Hagino Y; Yamamoto H; Koide T; Shiroishi T; Kasai K; Tsunashima K; Kato N; Ikeda K
    Pharmacogenet Genomics; 2008 Nov; 18(11):927-36. PubMed ID: 18854775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
    Reynolds KK; Ramey-Hartung B; Jortani SA
    Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
    Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
    Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic differences in response properties of rostral ventromedial medulla neurons to the μ-opioid receptor agonist DAMGO in mouse inbred strains.
    Sugino S; Namiki A; Yamakage M
    Neurosci Lett; 2012 May; 517(2):107-12. PubMed ID: 22546603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
    Hall FS; Goeb M; Li XF; Sora I; Uhl GR
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of genetic analysis of human opioid receptors.
    Spampinato SM
    Methods Mol Biol; 2015; 1230():3-12. PubMed ID: 25293312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.